The Government of Tamil Nadu has done a good job in preventing the spread of corona virus announced that the World Health Organization's medical officer Surendran. The Government of Tamil Nadu has been effective in preventing corona spread. An investigation is being carried out to ascertain whether arrangements, facilities and medical equipment have been made in government hospitals as a preventive measure for corona spread.
World Health Organization commends Tamil Nadu Government
Men are more vulnerable to coronavirus than women
Researchers have found that men seem to bemore vulnerable to COVID-19 than women. It suggested the reason might be related to the concentration of the enzyme Angiotensin-Converting Enzyme 2 (ACE2) in the blood of men and women. Key Findings: TheACE2 enzyme in blood responds to the novel coronavirus and enables it to infect the human cell. ACE2 is also a receptor present on the surface of healthy cells. TheSARS-CoV-2 virus uses this receptor to enter inside cells. ACE2 receptors are present in abundance in the lungs, heart, kidneys, and testes. The study found men have higher concentrations of ACE2 in their blood than women. It also showed heart failure patients who are taking a certain class of drugs, called RAAS inhibitors, did not have higher concentrations of ACE2 in their blood. But, some studies suggested RAAS inhibitors might increase ACE2 concentrations in blood plasma.
JNU to develop portable coronavirus testing device
TheJawaharlal Nehru University’s (JNU) is developing a low-cost, portable and battery-operated device to test coronavirus, the varsity said in a statement. According to JNU, the device can complete testing in 50 minutes while it takes 120-180 minutes through the conventional method. It has designed a chip-based spatial reverse transcription-polymerase chain reaction (RT-PCR) where PCR has been integrated with an in-built detection system containing LED and diode detector.
Scientists find coronavirus outbreak started late 2019
Investigators, who analysed virus genomes from over 7,500 infected people, find nearly 200 mutations in the SARS-CoV-2 virus since China's outbreak but say this does not mean it is getting deadlier. Scientists have found the coronavirus that causes Covid-19 has been in circulation since possibly October last year, evolving ever since it struck China with close to 200 "recurrent genetic mutations" in the virus. The study "Emergence of genomic diversity and recurrent mutations in SARS-CoV-2" was carried out by a group of international scientists led by University College London.
NIAB develops portable coronavirus detection kit “eCovSens”
The researchers from the Department of Biotechnology (DBT), National Institute of Animal Biotechnology (NIAB) developed a biosensor “eCovSens” to detect the novel coronavirus within 30 seconds using 20 microliters of the sample of saliva The Biosensors is currently used to detect toxins, narcotic drugs and used as a reliable tool to detect infectious diseases About NIAB: NIAB is an autonomous institute under the department of Biotechnology, Minister of Science and Technology. Headquarters– Hyderabad, Telangana.
Indian study finds 85% correlation between temperature rise and decrease in Coronavirus spread
A study by the National Environmental Engineering Research Institute (Neeri) in Nagpur has found a “very strong” correlation — up to 85% — between the increase in the average day temperature and the reduction in Covid-19 spread for select cities in the country and for states like Maharashtra and Karnatakaas a whole. Neeri, a constituent laboratory of the Council of Scientific and Industrial Research, based its research on a mathematical model. It sourced Covid-19 case data from the World Health Organisation and temperature data from India Meteorological Department. It studied the average real time temperature and relative humidity and their relationship with the rising Covid-19 cases in Maharashtra and Karnataka.
GBRC Scientists successfully sequence the whole genome of Coronavirus
A team of Indian Scientists at the Gujarat Biotechnology Research Centre (GBRC) successfully decode the whole genome sequence of the novel Coronavirus. The Gandhinagar-based GBRC is the first Indian Government laboratory to achieve this milestone. This achievement will help the scientists in their research on COVID-19 pandemic.
‘Medibot’ can treat coronavirus patients without risking infection
Malaysian scientists have created a barrel-shaped robot on wheels that they hope will make the rounds on hospital wards to check on coronavirus patients, reducing health workers' risk of infection. "Medibot" is a 1.5 metretall (five foot) white robot, equipped with a camera and screen via which patients can communicate remotely with medics.
Reliance General Insurance launches coronavirus protection insurance cover
Non-life insurer Reliance General Insurance on Wednesday launched a COVID-19 protection insurance scheme, which offers 100 per cent of the sum-insured in lump sum on positive diagnosis of coronavirus. The plan has a policy period of one year and the waiting period is for 15 days before one can claim against the policy, according to a statement by the company. The plan will cover anyone aged between 3 months and 60 years, for a sum-insured option from Rs 25,000 to Rs 2 lakh. It will also give cover for any loss of pay or job under separate add-ons in addition to the base policy.
India’s first coronavirus hospitalization insurance by PhonePe for Covid-19 treatment
The accelerated pace of coronavirus is affecting mankind adversely despite government efforts for curbing the situation. It is posing additional financial burden on individuals or families to get hospitalization treatment for COVID-19. To provide support for such cases, Digital payments company PhonePe has launched India’s first COVID-19 hospitalization insurance policy called Corona Carein collaboration with Bajaj Allianz General Insurance for people who have been infected and hospitalised for covid-19 treatment. The policy will provide an insurance cover of 50,000 on a one-time payment of Rs 156 for people who are under 55 yearsof age.